
Feel Therapeutics is a digital precision medicine company delivering objective data and passive measurement for mental health. The company develops physiological and digital biomarkers and therapeutics for mental health. Its Feel data monitoring device leverages five embedded sensors via the wristband. Feel collects biometric data and analyzes them using the latest cutting-edge methods of computer science to develop digital biomarkers.

Feel Therapeutics is a digital precision medicine company delivering objective data and passive measurement for mental health. The company develops physiological and digital biomarkers and therapeutics for mental health. Its Feel data monitoring device leverages five embedded sensors via the wristband. Feel collects biometric data and analyzes them using the latest cutting-edge methods of computer science to develop digital biomarkers.
What they do: Digital precision medicine company building passive physiological and digital biomarkers and personalized digital therapeutics for mental health
Founded / HQ: 2015; San Francisco (additional offices in Europe)
Founders / leadership: George Eleftheriou (Co‑Founder & CEO), Haris Tsirmpas, PhD (Co‑Founder & CTO)
Tech / product: Wearable wristband (Feel Emotion Sensor) with embedded sensors + mobile app; continuous 24/7 monitoring and AI algorithms
Funding signal: Multiple disclosed rounds; reported convertible note Apr 10, 2024; total funding figures reported variably (~$13.83M per some data; other reports cite ~$30M)
Mental and behavioral health; objective measurement and timely interventions
2015
Biotechnology
Latest listed convertible note dated April 10, 2024
Seed round participation listed (seed round date shown in some records)
“Has backing from venture investors including Felicis, Anthemis Exponential Ventures, SOSV, Satori Capital, Flight Ventures, and others”